Skip to main content

Table 1 Patients and clinicopathological characteristics

From: Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis

Variables No. of patients %
Age (median, IQR) 58 (51–65)  
Gender (male) 282 60.3
Smoking (yes) 132 28.2
Drinking (yes) 66 14.1
HBsAg (positive) 202 43.2
ALT (U/L) (median, IQR) 29 (16–59)  
ALB (g/L) (median, IQR) 38.4 (34.9–41.0)  
TBIL (μmol/L) (median, IQR) 13.4 (8.9–22.4)  
Child–Pugh grade (B) 126 26.9
Cirrhosis (yes) 222 47.4
LMR (median, IQR) 3.3 (2.1–4.8)  
NLR (median, IQR) 2.4 (1.7–3.7)  
PLR (median, IQR) 154.8 (102.0–245.3)  
AFP (μg/L) (median, IQR) 3.3 (2.3–10.7)  
CEA (μg/L) (median, IQR) 2.8 (1.7–4.4)  
CA19-9 (U/mL) (median, IQR) 74.3 (21.9–590.4)  
Tumor number (multiple) 107 22.9
Tumor diameter (> 5 cm) 208 44.4
VI (yes) 100 21.4
Lymph node metastasis (yes) 158 33.8
Tumor differentiation
 Well 36 7.7
 Moderate 346 73.9
 Poor 86 18.4
Type of hepatectomy (major) 256 54.7
Blood transfusion (yes) 134 28.6
Adjuvant chemotherapy (yes) 90 19.2
  1. IQR interquartile range, HBsAg hepatitis B surface antigen, ALT alanine aminotransferase, ALB albumin, TBIL total bilirubin, LMR lymphocyte to monocyte ratio, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, AFP α-fetoprotein, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9, VI vascular invasion